Intuitive Surgical, Inc. (NASDAQ:ISRG)‘s stock had its “overweight” rating reaffirmed by equities research analysts at Barclays PLC in a research report issued on Friday.
A number of other analysts also recently weighed in on the stock. Canaccord Genuity reaffirmed a “hold” rating on shares of Intuitive Surgical in a research report on Tuesday, October 17th. Wells Fargo & Company reaffirmed a “buy” rating on shares of Intuitive Surgical in a research report on Monday, October 16th. Wedbush reaffirmed a “buy” rating on shares of Intuitive Surgical in a research report on Tuesday, October 10th. Morgan Stanley reaffirmed an “overweight” rating on shares of Intuitive Surgical in a research report on Tuesday, September 5th. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and issued a $333.33 target price on shares of Intuitive Surgical in a research report on Friday, September 1st. Five investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $137.11.
Intuitive Surgical (ISRG) opened at 369.58 on Friday. The firm has a market capitalization of $41.19 billion, a PE ratio of 53.11 and a beta of 0.39. The stock’s 50 day moving average is $350.65 and its 200-day moving average is $313.46. Intuitive Surgical has a one year low of $203.57 and a one year high of $374.89.
Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 19th. The medical equipment provider reported $2.77 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.99 by $0.78. The firm had revenue of $806.10 million for the quarter, compared to the consensus estimate of $753.25 million. Intuitive Surgical had a net margin of 30.16% and a return on equity of 18.34%. The company’s revenue was up 18.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.06 EPS. On average, analysts anticipate that Intuitive Surgical will post $7.93 EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: “Barclays PLC Reiterates “Overweight” Rating for Intuitive Surgical, Inc. (ISRG)” was originally published by TrueBlueTribune and is the property of of TrueBlueTribune. If you are viewing this news story on another site, it was illegally stolen and republished in violation of United States & international trademark and copyright laws. The original version of this news story can be viewed at https://www.truebluetribune.com/2017/10/22/barclays-plc-reiterates-overweight-rating-for-intuitive-surgical-inc-isrg.html.
In other news, EVP Salvatore Brogna sold 899 shares of the firm’s stock in a transaction dated Friday, September 1st. The shares were sold at an average price of $1,001.90, for a total transaction of $900,708.10. Following the sale, the executive vice president now owns 570 shares of the company’s stock, valued at approximately $571,083. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Curet Myriam sold 1,202 shares of the firm’s stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $950.20, for a total transaction of $1,142,140.40. Following the sale, the senior vice president now directly owns 1,428 shares in the company, valued at approximately $1,356,885.60. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 23,172 shares of company stock worth $21,923,487. Insiders own 2.20% of the company’s stock.
Several hedge funds and other institutional investors have recently made changes to their positions in the company. APG Asset Management N.V. boosted its holdings in shares of Intuitive Surgical by 205.0% during the 3rd quarter. APG Asset Management N.V. now owns 86,882 shares of the medical equipment provider’s stock valued at $90,868,000 after acquiring an additional 58,400 shares during the last quarter. Meeder Asset Management Inc. purchased a new stake in shares of Intuitive Surgical during the 3rd quarter valued at about $1,563,000. Robeco Institutional Asset Management B.V. boosted its holdings in shares of Intuitive Surgical by 152.4% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 43,496 shares of the medical equipment provider’s stock valued at $45,491,000 after acquiring an additional 26,260 shares during the last quarter. Wealth Enhancement Advisory Services LLC purchased a new stake in shares of Intuitive Surgical during the 3rd quarter valued at about $2,524,000. Finally, Eqis Capital Management Inc. boosted its holdings in shares of Intuitive Surgical by 17.2% during the 3rd quarter. Eqis Capital Management Inc. now owns 408 shares of the medical equipment provider’s stock valued at $427,000 after acquiring an additional 60 shares during the last quarter. 31.41% of the stock is currently owned by hedge funds and other institutional investors.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.